Cancer is one of those devastating illnesses that is wide spread across the world. In some or fashion, everyone has been touched by this disease either directly or indirectly. Cancer is caused by many things and it can manifest in vital human organs. The urge to eradicate this deadly disease is foregoing and over the past decade or so, many advanced medications have been brought into play. Antibody Drug Conjugates, which labelled are cancer breakthrough therapies, have taken over the market thanks to their cancer fighting capabilities. These medication are aggressive as they’ll attack cancerous cells within the body then give them cell killing blows. Seattle Genetics of Bothell, Washington is the leader in cancer research as they produce these mighty medications in abundance.
Seattle Genetics specializes in the development and commercialization of these drugs and as of today, Forbesranked it as one of the fastest growing companies in the U.S. ADCETRIS is the flagship drug and it has racked up over $350 Million, which has caused the company’s stock to triple over a 5 year span. Of course any great company has to have great leadership and Seattle Genetics is no exception. DR. Clay Siegall is the head man in charge as well as the founder of this excellent organization. Dr. Siegall has natural talent for getting things done thanks to his determination, passion, and persistence. His resume speaks for itself as he’s written 70 successful publications, won numerous philanthropic awards, and he currently holds up to 15 patents. That’s right! The guy is literally a genius with the heart of gold.
No other word in the English vocabulary has the menace or impact of the single word, cancer. We all know of someone who appeared healthy, strong, confident but was taken by this dreaded disease all too early. While most people are offended by large drug manufacturers making millions from selling overpriced medications, we still cheer on the efforts of these same manufacturers to find a cure for cancer. One such company seeking a cure is Seattle Genetics, which is concentrating their efforts for an effective cure by the use of a special procedure whereby the agents do not attack randomly as in the devastating effects of chemotherapy but make a sophisticated assault on the cancer cells without damaging other necessary cells in the blood stream.
Seattle Genetics was co-founded by Clay Sigel in 1988 and continues to seek a cure for this devastating disease. Siegel has a B.S. in Zoology from The University of Maryland and obtained a Ph. D. from George Washington University in Genetics. Dr. Sigel has a long history of excellent work in the field of cancer research.
Cancer has been a disease plaguing men and women and doing irreparable harm to countless families. It even affects those searching for the cure. One renowned researcher in the field was diagnosed with cancer and openly refused one of the more damaging forms of treatment for his cancer. Breast Cancer awareness has a symbol and receives generous donations by all concerned about the devastating effects of a disease that does not discriminate between the sexes. There have been promising discoveries of drugs and procedures used, but the disease remains feared by everyone and without a great hope for an immediate cure. Research in genetics by Siegel and his company look promising, and all people hope he and Seattle Genetics can find relief for those suffering and for the millions who many contract the disease in the near future.